Identification and characterisation of deprescribing tools for older patients: A scoping review

Mejías-Trueba, Marta; B, Rubio; Rodríguez-Pérez, Aitana; Wittel, Máximo Bernabéu; Sánchez-Fidalgo, Susana

doi:10.1016/j.sapharm.2022.03.008

Cited by 5 publications

(1 citation statement)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We located a total of 56 articles in the Medline database (search through PubMed), and after screening each one's title and abstract excluded 46 articles based on the previously established inclusion and exclusion criteria. The complete manuscripts of all 15 potentially relevant articles were obtained for final evaluation, among which 12 provided a response to our research objective (table 1), with (Ali et al, 2020;Mejías-Trueba et al, 2022;Nizet et al, 2023) being excluded.…”

Section: Deprescribing and Its Application In The Elderly Populationmentioning

confidence: 99%

When Less Is More: The Role of Deprescribing in the Elderly - A Narrative Review of the Evidence

Teixeira,

Guimarães,

Soares

et al. 2024

RIAGE

View full text Add to dashboard Cite

The aging population is associated with an increase in elderly individuals with multimorbidity and the consequent polypharmacy. While appropriate in some cases, this often leads to the prescription of potentially inappropriate medications. Older individuals are more susceptible to adverse events due to pharmacodynamic and pharmacokinetic changes resulting from physiological alterations typical of aging, which interfere with drug metabolism. The aging process is complex, associated with multimorbidity, geriatric syndromes, functional and/or cognitive deficits, and, consequently, limited life expectancy. Currently, about 40% of the elderly are polymedicated. Deprescribing is an activeprocess of reviewing all of a patient's medications, performed by a physician, based on a risk/benefit assessment. Polypharmacy is associated with an increased risk of mortality, falls, drug interactions, and hospitalizations. The deprescribing process can lead to a reduction of about 39% in chronic medication, resulting in increased therapeutic adherence to the remaining drugs. Deprescribing is a fundamental pillar of person- centred care, and the population should be aware of its importance. A classic review was conducted through bibliographic research of systematic reviews on Medline. This narrative review aimed to address polypharmacy and its prevalence in the elderly population, evaluate the benefits and risks of deprescribing, and identify barriers and facilitating factors in the deprescribing process.

show abstract

Section: Deprescribing and Its Application In The Elderly Populationmentioning

confidence: 99%

When Less Is More: The Role of Deprescribing in the Elderly - A Narrative Review of the Evidence

Teixeira,

Guimarães,

Soares

et al. 2024

RIAGE

View full text Add to dashboard Cite

show abstract

Multidisciplinary DEprescribing review for Frail oldER adults in long-term care (DEFERAL): Implementation strategy design using behaviour science tools and stakeholder engagement

Heinrich¹,

McHugh²,

McCarthy³

et al. 2023

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to support a proactive approach

Denig,

Stuijt

2024

Expert Review of Clinical Pharmacology

View full text Add to dashboard Cite

Identification and characterisation of deprescribing tools for older patients: A scoping review

Cited by 5 publications

References 37 publications

When Less Is More: The Role of Deprescribing in the Elderly - A Narrative Review of the Evidence

When Less Is More: The Role of Deprescribing in the Elderly - A Narrative Review of the Evidence

Multidisciplinary DEprescribing review for Frail oldER adults in long-term care (DEFERAL): Implementation strategy design using behaviour science tools and stakeholder engagement

Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to support a proactive approach

Contact Info

Product

Resources

About